Phytochemicals, naturally occurring compounds in plants, offer significant potential for drug development due to their diverse structures and biological activities. They exhibit antioxidant, anti-inflammatory, antimicrobial, anticancer, cardiovascular, and neuroprotective properties, making them beneficial for treating various health conditions. Advantages of phytochemicals include their natural origin, better safety profiles, multi-targeted actions, synergistic effects with other compounds, and sustainability. However, the traditional knowledge-based approach to analizing phytochemicals is limited by its reliance on well-known, locally available plants, resulting in a narrow scope and frequent redundancy. This approach often depends on anecdotal and subjective evidence, faces the risk of knowledge loss, and encounters ethical and legal issues. To address this issue, I propose a convolutional neural network-based systematic approach to predict potential biological activities from molecular structure inputs. The proposed system converts molecular structures into one-hot vector representations using SMILES notation and molecular fingerprint algorithms. These vectors are then fed into a biological activity prediction network to estimate possible biological activities. Through comprehensive experiments, I have demonstrated that applying a convolutional neural network-based machine learning approach yields promising results by achieving an accuracy of 87.8%.